You have 9 free searches left this month | to do more

CD30.CAR-T

CD30.CAR T is a drug used to treat Anaplastic Large Cell Lymphoma, Extranodal NK/T-cell Lymphoma, Hodgkin Disease Recurrent, and other conditions. CD30.CAR T is being actively studied in 2 studies; no studies for this drug have been completed so far.

Top SponsorsTop SitesTop Investigators
Tessa TherapeuticsSarah Cannon Research Institute
Baylor College of Medicine
Children's Hospital of Philadelphia
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
T
Active, not recruiting
  • Hodgkin Lymphoma, Adult
  • +3 more
  • CD30.CAR-T
  • +2 more
  • Duarte, California
  • +4 more
2022-04-03
Apr 3, 2022
T
Recruiting
  • Anaplastic Large Cell Lymphoma
  • +4 more
  • CD30.CAR-T
  • Duarte, California
  • +3 more
2021-10-04
Oct 4, 2021